Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
106.82
(
-0.91%
)
Bitcoin
78,628.50
(
-0.07%
)
News Focus
News Focus
Post# of 375420
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3160
Posts 967892
Boards Moderated 152
Alias Born 09/04/2000

mick

Member Level

Re: Ardbeg post# 299204

Tuesday, 04/15/2014 7:10:50 PM

Tuesday, April 15, 2014 7:10:50 PM

Post# of 375420
what ah thorough reading/scenario of clinic possibilities revenues/\

http://investorshub.advfn.com/boards/post_reply.aspx?message_id=100645669

***Natures Cure III, LLC Revenue Potential Analysis DD – For QASP (Updated 4/15/14)

This analysis serves to provide some perspective to current, and potential, QASP investors. Since QASP is in negotiations with Natures Cure III, LLC I felt it was appropriate to provide a little financial and market analysis. Enjoy!

http://investorshub.advfn.com/boards/post_reply.aspx?message_id=100645669
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote